Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras
Between 1999-2002, Médécins Sans Frontières-Spain implemented a project seeking to determine the efficacy and safety of benznidazole in the treatment of recent chronic Chagas disease in a cohort of seropositive children in the Yoro Department, Honduras. A total of 24,471 children were screened for Trypanosoma cruzi IgG antibodies through conventional enzyme-linked immunosorbent assays (ELISA) on filter paper. Recombinant ELISA (0.93% seroprevalence) showed 256 initially reactive cases, including 232 confirmed positive cases. Of these, 231 individuals were treated with benznidazole (7.5 mg/kg/day) for 60 days and were followed with a strict weekly medical control and follow-up protocol. At the end of the project, 229 patients were examined by the Honduras Secretariat of Health for post-treatment serological assessments; 88.2% seroconverted after 18 months and 93.9% seroconverted after three years. No differences were found in the seroconversion rates according to age or sex. Most of the side effects of the treatment were minor. These results support the argument that in areas where T. cruzi I is predominant and in areas affected by T. cruzi II, when vector transmission has been interrupted, Chagas disease diagnosis and treatment are feasible, necessary and ethically indisputable.
Main Authors: | , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Instituto Oswaldo Cruz, Ministério da Saúde
2009
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000700008 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0074-02762009000700008 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0074-027620090007000082009-12-14Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, HondurasEscribà,Josep MPonce,ElisaRomero,Alberto de DiosViñas,Pedro AlbajarMarchiol,AndreaBassets,GlòriaPalma,Pedro PabloLima,M AngelesZúniga,ConcepciónPonce,Carlos Chagas disease drug therapy benznidazole indeterminate form Honduras Between 1999-2002, Médécins Sans Frontières-Spain implemented a project seeking to determine the efficacy and safety of benznidazole in the treatment of recent chronic Chagas disease in a cohort of seropositive children in the Yoro Department, Honduras. A total of 24,471 children were screened for Trypanosoma cruzi IgG antibodies through conventional enzyme-linked immunosorbent assays (ELISA) on filter paper. Recombinant ELISA (0.93% seroprevalence) showed 256 initially reactive cases, including 232 confirmed positive cases. Of these, 231 individuals were treated with benznidazole (7.5 mg/kg/day) for 60 days and were followed with a strict weekly medical control and follow-up protocol. At the end of the project, 229 patients were examined by the Honduras Secretariat of Health for post-treatment serological assessments; 88.2% seroconverted after 18 months and 93.9% seroconverted after three years. No differences were found in the seroconversion rates according to age or sex. Most of the side effects of the treatment were minor. These results support the argument that in areas where T. cruzi I is predominant and in areas affected by T. cruzi II, when vector transmission has been interrupted, Chagas disease diagnosis and treatment are feasible, necessary and ethically indisputable.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.104 n.7 20092009-11-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000700008en10.1590/S0074-02762009000700008 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Escribà,Josep M Ponce,Elisa Romero,Alberto de Dios Viñas,Pedro Albajar Marchiol,Andrea Bassets,Glòria Palma,Pedro Pablo Lima,M Angeles Zúniga,Concepción Ponce,Carlos |
spellingShingle |
Escribà,Josep M Ponce,Elisa Romero,Alberto de Dios Viñas,Pedro Albajar Marchiol,Andrea Bassets,Glòria Palma,Pedro Pablo Lima,M Angeles Zúniga,Concepción Ponce,Carlos Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras |
author_facet |
Escribà,Josep M Ponce,Elisa Romero,Alberto de Dios Viñas,Pedro Albajar Marchiol,Andrea Bassets,Glòria Palma,Pedro Pablo Lima,M Angeles Zúniga,Concepción Ponce,Carlos |
author_sort |
Escribà,Josep M |
title |
Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras |
title_short |
Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras |
title_full |
Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras |
title_fullStr |
Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras |
title_full_unstemmed |
Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras |
title_sort |
treatment and seroconversion in a cohort of children suffering from recent chronic chagas infection in yoro, honduras |
description |
Between 1999-2002, Médécins Sans Frontières-Spain implemented a project seeking to determine the efficacy and safety of benznidazole in the treatment of recent chronic Chagas disease in a cohort of seropositive children in the Yoro Department, Honduras. A total of 24,471 children were screened for Trypanosoma cruzi IgG antibodies through conventional enzyme-linked immunosorbent assays (ELISA) on filter paper. Recombinant ELISA (0.93% seroprevalence) showed 256 initially reactive cases, including 232 confirmed positive cases. Of these, 231 individuals were treated with benznidazole (7.5 mg/kg/day) for 60 days and were followed with a strict weekly medical control and follow-up protocol. At the end of the project, 229 patients were examined by the Honduras Secretariat of Health for post-treatment serological assessments; 88.2% seroconverted after 18 months and 93.9% seroconverted after three years. No differences were found in the seroconversion rates according to age or sex. Most of the side effects of the treatment were minor. These results support the argument that in areas where T. cruzi I is predominant and in areas affected by T. cruzi II, when vector transmission has been interrupted, Chagas disease diagnosis and treatment are feasible, necessary and ethically indisputable. |
publisher |
Instituto Oswaldo Cruz, Ministério da Saúde |
publishDate |
2009 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000700008 |
work_keys_str_mv |
AT escribajosepm treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT ponceelisa treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT romeroalbertodedios treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT vinaspedroalbajar treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT marchiolandrea treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT bassetsgloria treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT palmapedropablo treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT limamangeles treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT zunigaconcepcion treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras AT poncecarlos treatmentandseroconversioninacohortofchildrensufferingfromrecentchronicchagasinfectioninyorohonduras |
_version_ |
1756383644597878784 |